Image source: Getty Images. Specifically ... brain disorder spinocerebellar ataxia (SCA), by three months. The biotech has formally submitted troriluzole under the FDA's New Drug Application ...

FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...

The FDA is changing how drugs get approved—and that could unleash a biotech revolution. Dylan Jovine from Behind the Markets shares 4 biotech companies on the verge of explosive breakthroughs, ...

Chinese biotech company 3SBio's shares surged early Tuesday after its around US$6 billion licensing deal with Pfizer to develop, manufacture and commercialize a promising cancer drug. Shares were up ...

3SBio's shares surged 32% to 19.18 Hong Kong dollars, equivalent to US$2.45, on Tuesday after the Chinese company said it would receive an upfront payment of US$1.25 billion and potential milestone ...

Concord Biotech, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹1525. The stock has experienced fluctuations today ...

Volatile biotech stock Biohaven (NYSE: BHVN) is prone to sharp movements both up and down. On Thursday, it had one of its down days, with its share price eroding by almost 20% on a development ...

That brings us to Iovance Biotherapeutics ( IOVA -5.03%), a small-cap biotech that has significantly lagged the market over ...

Biotechnology company Regeneron Pharmaceuticals ... Related Articles Big Tech goes from stock market’s safest bet to biggest question Like it or not, the Like button has changed the world ...

HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial ... prompting the regulator to study how to revive the stock market. Shein, the Chinese fast-fashion business based in Singapore ...